{"nct_id":"NCT01626573","title":"A Study Exploring the Safety, Tolerability, and Efficacy of a 28 Day Course Followed by an Additional 56 Day Course of Itacitinib in Subjects With Active Rheumatoid Arthritis","status":"COMPLETED","status_verified_date":"2019-03","start_date":"2012-03","start_date_type":null,"primary_completion_date":"2013-07","primary_completion_date_type":"ACTUAL","completion_date":"2013-10","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["INCY"]}